Schedule 13G ownership disclosure

ProQR Therapeutics NV

Security class unavailable · CUSIP: N71542109

Event date: 2024-02-09

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
8,170,254
Percent of class
10.1000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-24-022674
Form type
SC 13G/A
Filer
ProQR Therapeutics N.V.
CIK
CIK 1612940
Filed
Feb 14, 2024
Reporting period
Feb 09, 2024
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub